Indication
Unresectable Sinonasal Tumors
1 clinical trial
2 products
5 drugs
Clinical trial
Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors: Phase II Study of Chemotherapy, Photon and Heavy Ion Radiotherapy Integration for More Effective and Less Toxic Treatment in Inoperable PatientsStatus: , Estimated PCD: 2020-06-01
Drug
CisplatinDrug
DocetaxelDrug
fluorouracilProduct
EtoposideDrug
R-CHOPProduct
IfosfamideDrug
mFOLFOX6